Chronic lymphocytic leukemia and Hodgkin's disease. Clinicopathologic study of three cases with good prognosis.

1. Reiter A, Schrappe M, Luwdig WD, et al. Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86. Blood 1994; 84:3122-33. 2. Wan JH, Trainor KJ, Brisco MJ, Morley AA. Monoclonality in B-cell lymphoma detected in paraffin wax embedded using the polymerase chain reaction. J Clin Pathol 1990; 43:888-90. 3. Brisco M, Condon J, Hughes E, et al. Outcome prediction in childhood acute lymphoblastic leukemia by molecular quantification of residual disease at the end of induction. Lancet 1994; 343:196-200. 4. Yokota S, Hansen-Hagge TE, Luwdig WD, et al. Use of polymerase chain reaction to monitor minimal residual disease in acute lymphoblastic leukemia patients. Blood 1991; 77:331-9. 5. Wasserman R, Galili N, Ito Y, et al. Residual disease at the end of induction therapy as a predictor of relapse during therapy in childhood B-lineage acute lymphoblastic leukemia. J Clin Oncol 1992; 10:1879-88. 6. Jacquy C, Delepant B, Van Daele S, et al. A prospective study of minimal residual disease in childhood B-lineage acute lymphoblastic leukemia: MRD level at the end of induction is a strong predictive factor of relapse. Br J Haematol 1997; 98:140-6. 7. Nizet Y, Martiat P, Vaerman JL, et al. Follow-up of residual disease (MRD) in B-lineage acute leukemia using a simplified PCR strategy: evolution of MRD rather than its detection is correlated with clinical outcome. Br J Haematol 1991; 79:205-10. 8. Roberts WM, Estrov Z, Ouspenskaia M, Johnston DA, McClain KL, Zipf TF. Measurement of residual leukemia during remission in childhood acute lymphoblastic leukemia. N Engl J Med 1997; 336:317-23. 9. Steenbergen EJ, Verhagen OJ, van Leewen EI, et al. Prolonged persistence of PCR detectable minimal residual disease after diagnosis or first relapse predicts poor outcome in childhood B-precursor acute lymphoblastic leukemia. Leukemia 1995; 9:1726-34. 10. Cave H, van der Werff ten Bosch J, Suciu S, et al. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer Childhood Leukemia Cooperative Group. N Engl J Med 1998; 339:591-8. Chronic lymphocytic leukemia and Hodgkin’s disease. Clinicopathologic study of three cases with good prognosis